X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (196) 196
Publication (42) 42
Patent (22) 22
Book / eBook (11) 11
Book Chapter (4) 4
Conference Proceeding (4) 4
Dissertation (3) 3
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (81) 81
index medicus (38) 38
female (30) 30
male (27) 27
oncology (23) 23
adult (22) 22
article (21) 21
middle aged (21) 21
cancer (19) 19
human necessities (19) 19
hygiene (19) 19
medical or veterinary science (19) 19
nitric oxide (19) 19
preparations for medical, dental, or toilet purposes (19) 19
aged (17) 17
animals (16) 16
antineoplastic agents - therapeutic use (14) 14
astronomy & astrophysics (14) 14
azo compounds - pharmacology (14) 14
js-k (14) 14
apoptosis (13) 13
hematology (13) 13
piperazines - pharmacology (13) 13
research (13) 13
treatment outcome (12) 12
antineoplastic agents - pharmacology (11) 11
in-vitro (11) 11
leukemia (11) 11
nccn clinical practice guidelines (11) 11
aged, 80 and over (10) 10
care and treatment (10) 10
hl-60 cells (10) 10
cell line, tumor (9) 9
gastroenterology & hepatology (9) 9
gastroenterology and hepatology (9) 9
nitric oxide donors - pharmacology (9) 9
analysis (8) 8
astrophysics (8) 8
chemistry, medicinal (8) 8
hematopoietic stem cell transplantation (8) 8
high energy astrophysical phenomena (8) 8
mice (8) 8
prognosis (8) 8
acute myeloid leukemia (7) 7
apoptosis - drug effects (7) 7
black hole physics (7) 7
bone-marrow-transplantation (7) 7
cells (7) 7
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (7) 7
leukemia, myeloid, acute - therapy (7) 7
prodrugs - pharmacology (7) 7
acute myeloid-leukemia (6) 6
angiogenesis (6) 6
antineoplastic agents - chemistry (6) 6
astrophysics - high energy astrophysical phenomena (6) 6
chemistry (6) 6
chronic myelogenous leukemia (6) 6
dasatinib (6) 6
differentiation (6) 6
endosonography (6) 6
galaxies: individual (6) 6
glutathione (6) 6
hemic and lymphatic diseases (6) 6
imatinib (6) 6
management (6) 6
mice, scid (6) 6
myelodysplastic syndromes - therapy (6) 6
nilotinib (6) 6
ophthalmology (6) 6
proteins (6) 6
retrospective studies (6) 6
time factors (6) 6
vivo (6) 6
abridged index medicus (5) 5
activation (5) 5
antineoplastic agents - administration & dosage (5) 5
antineoplastic agents - chemical synthesis (5) 5
astrophysics - instrumentation and methods for astrophysics (5) 5
azo compounds - chemistry (5) 5
biochemistry & molecular biology (5) 5
chronic myelomonocytic leukemia (5) 5
colony-stimulating factor (5) 5
diagnosis (5) 5
disease progression (5) 5
drug stability (5) 5
expression (5) 5
gravitational waves (5) 5
growth (5) 5
heterocyclic compounds (5) 5
immunology (5) 5
leukemia, myeloid, acute - drug therapy (5) 5
metallurgy (5) 5
nccn guidelines (5) 5
pharmacology & pharmacy (5) 5
pulsars: general (5) 5
stem-cell transplantation (5) 5
stents (5) 5
survival (5) 5
techniques: high angular resolution (5) 5
tyrosine kinase inhibitor (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (4) 4
UTL at Downsview - May be requested (4) 4
Victoria University E.J. Pratt - Stacks (3) 3
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
OISE - New Books (1) 1
OISE - Stacks (1) 1
Robarts - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (241) 241
French (11) 11
German (3) 3
Chinese (2) 2
Korean (2) 2
Spanish (2) 2
Arabic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 2109 - 2109
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 04/2015, Volume 32, Issue 4, p. 1395
  O^sup 2^-(2,4-dinitrophenyl)1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] or JS-K is a nitric oxide-producing prodrug of the arylated... 
Copolymers | Leukemia | Nitric oxide | Pharmacology | Cancer therapies
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 09/2013, Volume 65, Issue 9, pp. 1329 - 1336
Objective Nitric oxide (NO) possesses antitumour activity. It induces differentiation and apoptosis in acute myeloid leukaemia (AML) cells. The NO prodrug... 
leukaemia | poloxamer | JS‐K | nitric oxide | Pluronic | JS-K | Proteins | Studies | Lung cancer
Journal Article
Journal of Mammalogy, ISSN 0022-2372, 2004, Volume 85, Issue 4, pp. 625 - 632
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5127 - 5127
Abstract Nitric oxide (NO) is toxic to acute myeloid leukemia (AML) cells. The NO prodrug O2-(2,4-dinitrophenyl)... 
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 09/2013, Volume 11, Issue 9, pp. 1047 - 1055
These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support... 
SURVIVAL | ONCOLOGY | CONSOLIDATION THERAPY | ADULTS | TRANS-RETINOIC ACID | INTERGROUP | AIDA | APL | CHEMOTHERAPY | ACUTE PROMYELOCYTIC LEUKEMIA | ARSENIC TRIOXIDE
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5521 - 5521
Abstract Introduction:Chronic myelomonocytic leukemia (CMML) is a genetically heterogeneous myeloid neoplasm characterized by the presence of both dysplastic... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4426 - 4426
Abstract Background Anti-CD20 mAbs are an important element in the therapeutic armamentarium for B-cell malignancies such as chronic lymphocytic leukemia... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3979 - 3979
Abstract Introduction: Gemtuzumab ozogamicin (GO; MylotargTM) is an antibody-drug conjugate composed of an anti-CD33 monoclonal antibody covalently linked to... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5857 - 5857
Abstract INTRODUCTION: Mutation of FLT3, a tyrosine kinase receptor, is one of the most common molecular alterations in AML. In 2017, the FDA approved... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4745 - 4745
Abstract Introduction: Fms-like tyrosine kinase 3 (FLT3) gene mutation occurs in approximately 25-30% of acute myeloid leukemia (AML) cases and is associated... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.